Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rockwell Medical, Inc. - Common Stock (NQ:RMTI)

1.000 -0.020 (-1.96%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rockwell Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Earnings Preview: Rockwell Medical
Via Benzinga
Rockwell Medical to Showcase its Hemodialysis Concentrates Portfolio at DialysisTechConneXion40
From Rockwell Medical, Inc.
Via Business Wire
Rockwell Medical Named 'Great Place to Work'
From Rockwell Medical, Inc.
Via Business Wire
Rockwell Medical to Release Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30, 2023
From Rockwell Medical, Inc.
Via Business Wire
Rockwell Medical's Return On Capital Employed Overview
Via Benzinga
Analyst Hikes Price Target, Expects Rockwell Medical To Take Steps To Improve Debt Position
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Rockwell Medical and Concerto Renal Services Establish New Three-Year, Multi-Million Dollar Product Purchase Agreement
From Rockwell Medical, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Rockwell Medical Signs Three-Year, Multi-Million Dollar Supply Agreement with Largest Non-Profit Dialysis Provider in the United States
From Rockwell Medical, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning! 
Via InvestorPlace
Rockwell Medical Begins Selling its Hemodialysis Concentrates Products to New Clinics in Minnesota with its Largest Customer
From Rockwell Medical, Inc.
Via Business Wire
Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results
From Rockwell Medical, Inc.
Via Business Wire
Rockwell Medical Reacquires Distribution Rights for its Hemodialysis Concentrates Business from Baxter
From Rockwell Medical, Inc.
Via Business Wire
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14
From Rockwell Medical, Inc.
Via Business Wire
Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Rockwell Medical, Inc.
Via Business Wire
Rockwell Medical Names Heather Hunter SVP, Chief Corporate Affairs Officer
From Rockwell Medical, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock
HC Wainwright & Co. raised the price target for Rockwell Medical, Inc. (NASDAQ: RMTI) from $3 to $8. Rockwell Medical shares rose 0.7% to close at $1.42 on Monday. 
Via Benzinga
Rockwell Medical Announces Second Quarter 2022 Results
From Rockwell Medical, Inc.
Via Business Wire
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Novo Integrated Sciences (NASDAQ:NVOS) shares increased by 21.7% to $2.3 during Monday's after-market session. The market value of their outstanding shares is at $68.8 million. 
Via Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.